These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 8543941

  • 1. Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride.
    Rinne JO, Laihinen A, Ruottinen H, Ruotsalainen U, Någren K, Lehikoinen P, Oikonen V, Rinne UK.
    J Neurol Sci; 1995 Oct; 132(2):156-61. PubMed ID: 8543941
    [Abstract] [Full Text] [Related]

  • 2. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A, Vontobel P, Psylla M, Günther I, Maguire PR, Missimer J, Leenders KL.
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone.
    Kaasinen V, Ruottinen HM, Någren K, Lehikoinen P, Oikonen V, Rinne JO.
    J Nucl Med; 2000 Jan; 41(1):65-70. PubMed ID: 10647606
    [Abstract] [Full Text] [Related]

  • 4. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
    Antonini A, Schwarz J, Oertel WH, Pogarell O, Leenders KL.
    Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
    [Abstract] [Full Text] [Related]

  • 5. D2 receptor binding in dopa-responsive dystonia.
    Künig G, Leenders KL, Antonini A, Vontobel P, Weindl A, Meinck HM.
    Ann Neurol; 1998 Nov; 44(5):758-62. PubMed ID: 9818931
    [Abstract] [Full Text] [Related]

  • 6. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
    Tedroff J, Pedersen M, Aquilonius SM, Hartvig P, Jacobsson G, Långström B.
    Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
    [Abstract] [Full Text] [Related]

  • 7. [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.
    Antonini A, Schwarz J, Oertel WH, Beer HF, Madeja UD, Leenders KL.
    Neurology; 1994 Jul; 44(7):1325-9. PubMed ID: 8035939
    [Abstract] [Full Text] [Related]

  • 8. Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients.
    Politis M, Wilson H, Wu K, Brooks DJ, Piccini P.
    Neuroimage Clin; 2017 Jul; 16():455-460. PubMed ID: 28879087
    [Abstract] [Full Text] [Related]

  • 9. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
    Brooks DJ, Ibanez V, Sawle GV, Playford ED, Quinn N, Mathias CJ, Lees AJ, Marsden CD, Bannister R, Frackowiak RS.
    Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457
    [Abstract] [Full Text] [Related]

  • 10. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
    Antonini A, Leenders KL, Vontobel P, Maguire RP, Missimer J, Psylla M, Günther I.
    Brain; 1997 Dec; 120 ( Pt 12)():2187-95. PubMed ID: 9448574
    [Abstract] [Full Text] [Related]

  • 11. Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors.
    Rinne JO, Hublin C, Partinen M, Ruottinen H, Ruotsalainen U, Någren K, Lehikoinen P, Laihinen A.
    Neurology; 1995 Sep; 45(9):1735-8. PubMed ID: 7675236
    [Abstract] [Full Text] [Related]

  • 12. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
    Farde L, Wiesel FA, Stone-Elander S, Halldin C, Nordström AL, Hall H, Sedvall G.
    Arch Gen Psychiatry; 1990 Mar; 47(3):213-9. PubMed ID: 1968328
    [Abstract] [Full Text] [Related]

  • 13. Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride.
    Antonini A, Leenders KL, Reist H, Thomann R, Beer HF, Locher J.
    Arch Neurol; 1993 May; 50(5):474-80. PubMed ID: 8489403
    [Abstract] [Full Text] [Related]

  • 14. Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.
    Thobois S, Fraix V, Savasta M, Costes N, Pollak P, Mertens P, Koudsie A, Le Bars D, Benabid AL, Broussolle E.
    J Neurol; 2003 Oct; 250(10):1219-23. PubMed ID: 14586606
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride.
    Antonini A, Leenders KL.
    Ann N Y Acad Sci; 1993 Sep 24; 695():81-5. PubMed ID: 8239318
    [Abstract] [Full Text] [Related]

  • 16. The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagonist [³H]raclopride and the novel CB₁ inverse agonist [¹²⁵I]SD7015.
    Farkas S, Nagy K, Jia Z, Harkany T, Palkovits M, Donohou SR, Pike VW, Halldin C, Máthé D, Csiba L, Gulyás B.
    Brain Res Bull; 2012 Apr 10; 87(6):504-10. PubMed ID: 22421165
    [Abstract] [Full Text] [Related]

  • 17. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
    Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, Sanchez-Pernaute R, de Yébenez JG, Boesiger P, Weindl A, Maguire RP.
    Brain; 1996 Dec 10; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
    [Abstract] [Full Text] [Related]

  • 18. Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride.
    Rinne JO, Hietala J, Ruotsalainen U, Säkö E, Laihinen A, Någren K, Lehikoinen P, Oikonen V, Syvälahti E.
    J Cereb Blood Flow Metab; 1993 Mar 10; 13(2):310-4. PubMed ID: 8436624
    [Abstract] [Full Text] [Related]

  • 19. PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease.
    Rinne JO, Laihinen A, Rinne UK, Någren K, Bergman J, Ruotsalainen U.
    Mov Disord; 1993 Apr 10; 8(2):134-8. PubMed ID: 8474478
    [Abstract] [Full Text] [Related]

  • 20. A link between synaptic plasticity and reorganization of brain activity in Parkinson's disease.
    Rebelo D, Oliveira F, Abrunhosa A, Januário C, Lemos J, Castelo-Branco M.
    Proc Natl Acad Sci U S A; 2021 Jan 19; 118(3):. PubMed ID: 33431672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.